Presenting Companies



Approx. 25 innovative start-up orthopedic and spine device companies will present at JointVentures 2010

Confirmed presenters to date are listed below; check back often for the latest updates. Call 949-559-5511 or e-mail info@biomedgps.com if you are interested in becoming a presenter at this event.

 

Accelalox is developing bone regeneration therapies using small molecule inhibitors delivered orally and locally for bone fractures, spinal fusions and other orthopedic indications.

Articular Engineering, LLC is an orthobiologics company focused on repair and regeneration of cartilage and the spinal disc using cell-based and tissue-modifying technologies.

Bone Biologics is a convergence biotechnology company focused in the Orthobiologics space. The target markets for the Company's unique UCB-1 protein-based technologies are bone and cartilage regeneration.

CoreSpine develops enabling devices for lumbar spine tissue removal, clinically fulfilling a large unmet need in minimally invasive fusion procedures.

Echometrix is a developer of proprietary ultrasound systems providing a functional assessment of soft tissue pathologies, improving physical rehabilitation outcomes.

IMDS is a contract medical device development company specializing in joint replacement, spine, sports medicine, craniofacial, and trauma products. We will be demonstrating several technologies available for licensing.

Life Spine is a developer, manufacturer and marketer of proprietary medical devices serving the spinal implant communities.

The company’s flagship product, LifeMOD, is an innovative human simulation program that helps orthopedic manufacturers to eliminate the traditional cadaver-based design cycle.

MTF Sports Medicine is the leading provider of human allografts for sports medicine injuries and is focusing on the development of innovative approaches for the treatment of focal cartilage lesions.

NociMed’s mission is to develop and commercialize improved, cost effective approaches for diagnosing and localizing discogenic pain associated with degenerative disc disease.

Orteq markets a polymer scaffold to repair irreparable meniscal damage. The proprietary polymer platform has many other sports medicine applications.

OrthoCor Medical is an innovator of ambulatory, non-invasive therapeutic devices that utilize PEMF and thermal technologies to help patients alleviate joint pain and arthritis.

A bio-science company dedicated to improving the resources available for treating children's orthopedic conditions through inventing, designing, and distributing innovative and anatomically appropriate implants, unique instrumentation and biologics for pediatric and small stature patients.

OrthoX is focused on reducing the limitations placed on patients by providing high performance products for orthopedic surgery. The company’s early focus has been on high fatigue bone cements and associated mixing systems.

Novel Fibroblast Growth Factor variants (FGF2v, FGF4v, FGF9v) for therapeutic and reagent/cell expansion applications with a commercial focus on articular cartilage repair and regeneration.

Small Bone Innovations, Inc. is the only orthopedics company to focus purely on technologies for treating small bones and joints - the fastest growing industry sector.

Soft Tissue Regeneration, Inc. has developed a biodegradable scaffold to regenerate the ACL of the knee.

SpineAlign Medical, Inc., is an early-stage medical device company dedicated to the design, development and successful commercialization of minimally-invasive products for spine procedures.

Founded by surgeons, SpineFrontier designs, develops and markets innovative devices and solutions focused on less exposure spine surgery.

TissueGene employs a form of cell therapy to deliver therapeutic proteins to regenerate damaged cartilage, bone, disc and nerve tissue.